Clincosm LogoSign in Get a demo

kidney cancer

Showing 1 - 25 of 405
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Prostate Cancer, Kidney Cancer Trial in Chambersburg (High intensity approach, Low intensity approach)

Not yet recruiting
  • Prostate Cancer
  • Kidney Cancer
  • High intensity approach
  • Low intensity approach
  • Chambersburg, Pennsylvania
    Wellspan
Nov 21, 2023

Kidney Cancer, Lymphomas, Positron Emission Tomography Trial in Shanghai ([18F]RCCB6 PET Imaging)

Recruiting
  • Kidney Cancer
  • +2 more
  • [18F]RCCB6 PET Imaging
  • Shanghai, China
    Huashan Hospital
Nov 19, 2023

MRI Guided Radiotherapy and Radiobiological Data: ISRAR Database

Not yet recruiting
  • Prostate Cancer
  • +4 more
  • 3 MRI sequences (T2*, IVIM and Multi Echo-Gradient), without injection, are performed
  • (no location specified)
Sep 18, 2023

Kidney Cancer Trial in Cambridge (Magnetic Resonance Imaging)

Recruiting
  • Kidney Cancer
  • Magnetic Resonance Imaging
  • Cambridge, Cambridgeshire, United Kingdom
    University Department of Radiology
Aug 23, 2023

Renal Cancer, Kidney Cancer, Renal Cell Carcinoma Trial in Aurora (Axitinib, Pembrolizumab)

Not yet recruiting
  • Renal Cancer
  • +3 more
  • Aurora, Colorado
    University of Colorado Cancer Center
Jul 24, 2023

Sarcoma, Carcinoma, Digestive Cancer Trial in Linyi (Recombinant oncolytic herpes simplex virus type 1 (R130))

Recruiting
  • Sarcoma
  • +9 more
  • Recombinant oncolytic herpes simplex virus type 1 (R130)
  • Linyi, Shandong, China
    Linyi Central Hospital
Jul 25, 2023

Survivorship, Prostate Cancer, Kidney Cancer Trial in Cork (Physiotherapy, Dietitian Support, Nursing and Psychosocial)

Recruiting
  • Survivorship
  • +5 more
  • Physiotherapy
  • +2 more
  • Cork, Ireland
    Cork University Hospital
Jul 17, 2023

Clear Cell Kidney Cancer, Kidney Cancer, Kidney Cancer With PBRM1/BAP1/VHL/SETD2 Mutations Trial (Axitinib 5 MG)

Available
  • Clear Cell Kidney Cancer
  • +2 more
  • Axitinib 5 MG
  • (no location specified)
Jul 3, 2023

ccRCC, Clear Cell Renal Cell Carcinoma, Kidney Cancer Trial (NKT2152, palbociclib, sasanlimab)

Not yet recruiting
  • ccRCC
  • +20 more
  • (no location specified)
Jul 6, 2023

Carcinoma, Renal Cell Carcinoma, RCC Trial in Nanjing

Recruiting
  • Carcinoma
  • +4 more
    • Nanjing, Jiangsu, China
      Jinling Hospital, Affiliated Hospital of Medical School, Nanjing
    Jun 30, 2023

    Urologic Cancer, Urologic Tumors, Bladder Cancer Trial in Boston (Electromagnetic Guided Laparoscopy, Ultrasound)

    Not yet recruiting
    • Urologic Cancer
    • +7 more
    • Electromagnetic Guided Laparoscopy
    • Ultrasound
    • Boston, Massachusetts
      Brigham and Women's Hospital
    Jun 8, 2023

    Skin Health and Quality of Life in Patients Receiving

    Not yet recruiting
    • Lung Cancer
    • +7 more
    • EQ-5D-5L questionnaire
    • +2 more
    • Roma, Italy
      Roberto Iacovelli
    May 17, 2023

    Solid Tumor, Adult, Advanced Solid Tumor, Head Neck Cancer Trial in Irving, San Antonio, West Valley City (SNS-101 (anti-VISTA),

    Recruiting
    • Solid Tumor, Adult
    • +19 more
    • Irving, Texas
    • +2 more
    May 24, 2023

    Breast Cancer, Hodgkin Lymphoma, Kidney Cancer Trial (Assessment tool IA3-CP with SDoH, Assessment tool IA3-CP without SDoH)

    Not yet recruiting
    • Breast Cancer
    • +9 more
    • Assessment tool IA3-CP with SDoH
    • Assessment tool IA3-CP without SDoH
    • (no location specified)
    May 22, 2023

    Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

    Not yet recruiting
    • Relapse
    • +7 more
    • Visakhapatnam, Andhra Pradesh, India
    • +5 more
    May 7, 2023

    Kidney Cancer, Renal Cancer, Renal Tumor Trial in Miami (Ketorolac, Acetaminophen, Oxycodone)

    Not yet recruiting
    • Kidney Cancer
    • +2 more
    • Miami, Florida
      University of Miami
    Apr 24, 2023

    oncRNA Stratification of Cancer by Size and Stage

    Not yet recruiting
    • Kidney Cancer
    • +32 more
    • Exai oncRNA blood test
    • (no location specified)
    Apr 27, 2023

    Renal Cancer, Tumor, Solid, Kidney Cancer Trial (HistoSonics Edison System)

    Not yet recruiting
    • Renal Cancer
    • +4 more
    • HistoSonics Edison System
    • (no location specified)
    Apr 18, 2023

    Prostate Cancer, Kidney Cancer, Constipation Trial in Iowa City (Polyethylene Glycol 3350)

    Recruiting
    • Prostate Cancer
    • +2 more
    • Polyethylene Glycol 3350
    • Iowa City, Iowa
      University of Iowa Hospitals & Clinics
    Mar 22, 2023

    Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

    Not yet recruiting
    • Prostate Cancer
    • +11 more
    • Guided physical exercise
    • +2 more
    • Tampere, Länsi-Suomi, Finland
      Tampere University Hospital
    Apr 3, 2023

    Kidney Cancer, Clear Cell Renal Cell Carcinoma Metastatic, Synchronous Tumor Trial in Seoul (Cytoreductive

    Recruiting
    • Kidney Cancer
    • +2 more
    • Cytoreductive nephrectomy±metastasectomy
    • Human-derived materials sampling
    • Seoul, Korea, Republic of
      Yonsei University Health System, Severance Hospital
    Mar 2, 2023

    Cancer, Solid Tumor, Melanoma Trial (KVA12123 - Dose Escalation, KVA12123 Plus Pembrolizumab - Dose Escalation, KVA12123 - Dose

    Not yet recruiting
    • Cancer
    • +16 more
    • KVA12123 - Dose Escalation
    • +3 more
    • (no location specified)
    Feb 2, 2023

    Cancer, Solid Tumor, Colorectal Cancer Trial (biological, radiation, drug)

    Not yet recruiting
    • Cancer
    • +8 more
    • DK210 (EGFR)
    • +3 more
    • (no location specified)
    Jan 27, 2023

    Von Hippel-Lindau: Clinical Manifestations, Diagnosis,

    Recruiting
    • Kidney Cancer
    • +4 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 25, 2023

      Renal Cell Carcinoma, Metastatic Renal Cell Carcinoma, Kidney Cancer Trial in Boston (Implantable Microdevice (IMD))

      Not yet recruiting
      • Renal Cell Carcinoma
      • +2 more
      • Implantable Microdevice (IMD)
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Jan 17, 2023